National HealthCare (NHC) 8-K Flags New Dividend Press Release

Rhea-AI Filing Summary

National HealthCare Corporation (NHC) filed a Form 8-K dated 8 Aug 2025 reporting Item 8.01 – Other Events. The filing states that on 7 Aug 2025 the company issued a press release announcing its quarterly common-stock dividend. The press release is furnished as Exhibit 99.1 and is incorporated by reference. No dividend amount, record date, or payment date is disclosed within the 8-K itself, and no additional financial data or material transactions are presented.

Positive

• NHC formally announced a quarterly common-stock dividend, indicating the company intends to return capital to shareholders.

Negative

• Dividend amount and key dates are not disclosed in the 8-K filing, requiring investors to seek the exhibit for critical details.

Insights

Financial Analyst

TL;DR: Routine 8-K; dividend announced, no details; low investor impact.

This is a standard compliance filing. It simply alerts investors that a press release announcing a quarterly dividend was issued and attached as an exhibit. Because the dividend’s size and schedule are not included, the document does not provide enough information to alter valuation models or near-term forecasts. Absent any financial statements or guidance, the disclosure is largely procedural and should be considered immaterial to the company’s risk-return profile until the actual dividend figures are reviewed.

false 0001047335 0001047335 2025-08-07 2025-08-07

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 8, 2025 (August 7, 2025)

NATIONAL HEALTHCARE CORPORATION

(Exact name of registrant as specified in its charter)

Delaware (State or other jurisdiction of incorporation)	001-13489 (Commission File Number)	52-2057472 (I.R.S. Employer Identification No.)
100 E. Vine Street Murfreesboro, Tennessee (Address of Principal Executive Offices)		37130 (Zip Code)

Registrant’s telephone number, including area code: (615) 890-2020

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $.01 par value	NHC	NYSE American

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1988 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards pursuant to Section 13(a) of the Exchange Act. ☐

ITEM 8.01.         OTHER EVENTS.

NHC issued a press release on August 7, 2025, announcing its quarterly common dividend. The entire press release is attached as Exhibit 99.1 and is incorporated by reference herein.

ITEM 9.01.         FINANCIAL STATEMENTS AND EXHIBITS.

(d)         Exhibits.

Exhibit No.	Description of Exhibit
99.1	Copy of press release issued on August 7, 2025, by National HealthCare Corporation announcing quarterly common dividend.
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:         August 8, 2025

	NATIONAL HEALTHCARE CORPORATION
	By:/s/	Brian F. Kidd
	Name:	Brian F. Kidd
	Title:	Senior VP/Chief
		Financial Officer

FAQ

What did NHC disclose in its 8-K filed on August 8, 2025?

The company reported that it issued a press release announcing its quarterly common dividend and furnished that release as Exhibit 99.1.

Does the 8-K state NHC's dividend amount or payment date?

No. The filing references the press release but does not include dividend amount, record date, or payment date.

Which exhibit contains NHC's dividend press release?

Exhibit 99.1 contains the full press release dated August 7, 2025.

Is any financial statement included in this 8-K?

No financial statements or additional material events are provided in this filing.

Why is this 8-K important to NHC investors?

It notifies shareholders of a forthcoming dividend, but they must read the exhibit for specifics before assessing impact.